An Interventional Phase III, Open-Label, Randomized Study to Evaluate Efficacy and Safety of PF-08634404 in Combination with Chemotherapy versus Pembrolizumab in Combination with Chemotherapy in Adult Participants with Advanced or Recurrent Mismatch Repair Proficient Endometrial Cancer

Clinical Trial Information

Trial Phone: 321-841-7246

Principal Investigator: Shelly Seward, MD

Phase: III

Age Group: ADULTOLDER_ADULT

ClinicalTrials.gov ID: NCT07578649

Share:

Related Clinical Trials

Study of a New Device for Severe Asthma (PULSAR)
A Randomized, Open-Label Phase III Study of Azenosertib versus Investigator's Choice of Chemotherapy in Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
Multicenter research for the application and verification of the performance of the Necker Cranial Injury Scale (NCIS) as a predictor of in-hospital mortality in children and adolescents (<17 y-o) with severe traumatic brain injury (sTBI)
Phase 3 Study of XEN1101 in Primary Generalized Tonic-Clonic Seizures